Dec 29 (Reuters) - Ultragenyx Pharmaceutical (RARE.O), opens new tab said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to reduce the number of fractures ...

New research suggests GLP-1 medications may help reduce bone fracture risk in adults with type 2 diabetes, offering another ...

GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests. As these conditions are all ...

Millions of people worldwide suffer from osteoporosis, a disease marked by progressive bone loss, weakened skeletal strength ...

Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...

For decades, the first-line treatment for osteoporosis was a type of medication called antiresorptive agents, which work by slowing down the rate of bone loss. Now, though, there’s a newer treatment ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...

For many people, cancer is thought of as a disease that stays confined to one part of the body. However, some cancers have ...